Cabgolin: Advanced Dopamine Agonist Therapy for Hyperprolactinemia
Cabgolin
| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | 5.23 $ | 156.78 $ (0%) | 🛒 Add to cart |
| 60 | 4.78 $ | 313.56 $ 286.65 $ (9%) | 🛒 Add to cart |
| 90 | 4.63 $
Best per pill | 470.34 $ 416.52 $ (11%) | 🛒 Add to cart |
Cabgolin, containing the active ingredient cabergoline, is a potent dopamine receptor agonist specifically formulated for the management of hyperprolactinemic disorders. It is indicated for the treatment of idiopathic or pituitary adenoma-induced hyperprolactinemia, aiding in the reduction of prolactin secretion and restoration of gonadal function. With its long half-life and selective action, Cabgolin offers a convenient and effective therapeutic option for patients requiring sustained prolactin suppression.
Features
- Active ingredient: Cabergoline 0.5 mg per tablet
- Pharmacological class: Dopamine D2 receptor agonist
- Administration: Oral tablet
- Half-life: Approximately 63–69 hours
- Bioavailability: 40–50%
- Excretion: Primarily fecal (72%) and urinary (18–20%)
Benefits
- Effectively suppresses elevated prolactin levels, restoring normal endocrine function.
- Facilitates reduction in prolactinoma size, alleviating mass effect symptoms.
- Improves fertility and restores ovulation in women with hyperprolactinemia.
- Enhances testosterone levels and libido in affected men.
- Allows for less frequent dosing due to prolonged half-life, improving adherence.
- Minimizes risk of rebound hyperprolactinemia with gradual dose titration.
Common use
Cabgolin is primarily prescribed for the treatment of hyperprolactinemia, whether idiopathic or due to pituitary prolactinomas. It is also utilized in the management of Parkinson’s disease symptoms at higher doses, though its most frequent application remains endocrine-related. Off-label uses may include the prevention of physiological lactation and adjunctive therapy in acromegaly.
Dosage and direction
The initial dose for hyperprolactinemia is typically 0.25 mg twice weekly, which may be increased by 0.25 mg increments at 4-week intervals based on prolactin level response. Maximum recommended dose is 1 mg twice weekly. Tablets should be taken orally with or without food, though consistency in administration is advised. For Parkinson’s disease, dosing is higher and titrated individually under specialist supervision.
Precautions
Patients should be monitored for signs of cardiac valvulopathy, particularly with long-term use or higher doses. Caution is advised in patients with hepatic impairment, as cabergoline is extensively metabolized in the liver. Blood pressure should be regularly checked due to risk of orthostatic hypotension. Use with care in patients with psychiatric history, as dopamine agonists may exacerbate conditions.
Contraindications
Cabgolin is contraindicated in patients with hypersensitivity to cabergoline or any ergot derivatives. It should not be used in patients with uncontrolled hypertension, history of cardiac valvular disease, or pericardial fibrosis. Concomitant use with other dopamine antagonists is not recommended. Avoid in pregnancy unless clearly needed and benefits outweigh risks.
Possible side effect
Common side effects include nausea, headache, dizziness, and fatigue. Less frequently, patients may experience orthostatic hypotension, constipation, or abdominal pain. Rare but serious adverse effects include cardiac valvulopathy, pleural effusion, and psychiatric manifestations such as impulse control disorders. Fibrotic reactions and visual disturbances have also been reported.
Drug interaction
Cabgolin may interact with dopamine antagonists (e.g., antipsychotics, metoclopramide), reducing its efficacy. Concomitant use with antihypertensives may potentiate hypotension. Macrolide antibiotics and CYP3A4 inhibitors can increase cabergoline plasma levels, necessitating dose adjustment. Avoid combination with other ergot derivatives due to additive effects.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose may include severe nausea, vomiting, hypotension, hallucinations, or psychosis. Management is supportive, including gastric lavage if ingestion was recent and administration of activated charcoal. Hemodynamic support and symptomatic treatment for hypotension or psychiatric effects should be provided as necessary.
Storage
Store at room temperature (15–30°C) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a healthcare provider for diagnosis, treatment decisions, and personalized dosage recommendations. Do not initiate or discontinue Cabgolin without medical supervision.
Reviews
Clinical studies and patient reports indicate high efficacy in normalizing prolactin levels and improving associated symptoms, with many users noting convenience of twice-weekly dosing. Some reports highlight side effects such as nausea or dizziness, though these often diminish with continued use. Long-term safety data support its use under regular monitoring.